Abstract
In this project we intend to demonstrate that the use of arginine vasopressin would not only be more effective on the treatment of vasoplegic syndrome than conventional catecholamine vasopressors (especially norepinephrine), but also decrease the incidence of postoperative infections in patients undergoing cardiac surgery under cardiopulmonary bypass. We believe that this improvement in p…